Error message
Notice: Undefined index: content in _drupal_default_html_head() (line 345 of /var/www/vhosts/rovi.es/httpdocs/includes/common.inc).
|
Date |
Title |
Description |
PDF |
|
21 Feb 2023 |
On business and financial situation |
The company releases the Integrated Report for the year 2022
|
Download |
|
21 Feb 2023 |
About Corporate Governance |
The Company informs about the agreements adopted by the Board of Directors
|
Download |
|
23 Nov 2022 |
On business and financial situation |
The Company releases the presentation related to its strategy update because of its 2022 Capital Markets Day
|
Download |
|
04 Nov 2022 |
On business and financial situation |
The Company releases the press release related to the first nine months of 2022 financial results
|
Download |
|
04 Nov 2022 |
On business and financial situation |
The Company releases the first nine months 2022 financial results presentation
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
05 Apr 2022 |
Liquidity and counterparty agreements |
The Company communicates that it has entered into a liquidity agreement with Bestinver S.V., S.A.
|
Download |
|
29 Mar 2022 |
Share buy-back , stabilisation and treasury stock programme |
Share Buyback Program: transactions conducted on 28 March 2022 and end of the share buyback program
|
Download |
|
28 Mar 2022 |
Share buy-back , stabilisation and treasury stock programme |
Share Buyback Program: transactions conducted between 21 March 2022 and 25 March 2022
|
Download |
|
21 Mar 2022 |
Share buy-back , stabilisation and treasury stock programme |
Share Buyback Program: transactions conducted between 14 March 2022 and 18 March 2022
|
Download |
|
14 Mar 2022 |
Share buy-back , stabilisation and treasury stock programme |
Share Buyback Program: transactions conducted between 7 March 2022 and 11 March 2022
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
06 Apr 2017 |
Contratos de liquidez y contrapartida |
Liquidity contract: transactions conducted in the first quarter of 2017
|
Download |
|
13 Mar 2017 |
Otros sobre negocio y situación financiera |
The Company releases the presentation related to its biosimilar of Enoxaparin
|
Download |
|
07 Mar 2017 |
Otros sobre negocio y situación financiera |
ROVI informs that the Decentralised procedure used for the registration of its biosimilar of enoxaparin has been completed with positive outcome
|
Download |
|
16 Feb 2017 |
Otros sobre Gobierno Corporativo |
The Company informs about the agreements adopted by the Board of Directors
|
Download |
|
16 Feb 2017 |
Informe anual de remuneraciones de los consejeros |
ROVI releases the 2016 annual report regarding remuneration of the members of the Board of Directors
|
Download |
Pages
